Bram T. Ramaekers

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 96 publications

Risk-based selection for carotid revascularisation using the IMPROVE score versus standard care in symptomatic carotid artery disease: a model-based cost-effectiveness analysis using pooled-data.

Risk-based selection for carotid revascularisation using the IMPROVE score versus standard care in symptomatic carotid artery disease: a model-based cost-effectiveness analysis using pooled-data.

Journal: BMJ open

Published: May 28, 2026

An independent evaluation of an architectural-based scoring system for renal cell carcinoma risk-stratification.

An independent evaluation of an architectural-based scoring system for renal cell carcinoma risk-stratification.

Journal: Pathology, research and practice

Published: May 26, 2026

Assessing the impact of proton versus photon therapy on health-related quality of life in lung cancer.

Assessing the impact of proton versus photon therapy on health-related quality of life in lung cancer.

Journal: Clinical and translational radiation oncology

Published: January 27, 2026

Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer.

Post-radiotherapy health utility and symptom trends in patients with non-metastatic head and neck cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 26, 2025

Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers.

Renal cell carcinoma detection: a systematic review in diagnostic urinary biomarkers.

Journal: BMC cancer

Published: June 18, 2025

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Cost-Effectiveness of Pembrolizumab Monotherapy for High Programmed Death Ligand 1 Advanced or Metastatic Non-small Cell Lung Cancer Depends on Long-Term Survivors.

Journal: Clinical drug investigation

Published: June 04, 2025

Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome.

Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome.

Journal: The Journal of investigative dermatology

Published: March 19, 2025

Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands.

Adaptable framework for cost-analyses in radiotherapy: Application to the cost of proton versus photon therapy for lung cancer in The Netherlands.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: October 07, 2024

Forecasting the value of innovation in total knee arthroplasty care: A headroom approach.

Forecasting the value of innovation in total knee arthroplasty care: A headroom approach.

Journal: Journal of experimental orthopaedics

Published: September 16, 2024

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

Challenges in the Assessment of a Disease Model in the NICE Single Technology Appraisal of Tirzepatide for Treating Type 2 Diabetes: An External Assessment Group Perspective.

Journal: PharmacoEconomics

Published: April 30, 2024

Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.

Software with artificial intelligence-derived algorithms for analysing CT brain scans in people with a suspected acute stroke: a systematic review and cost-effectiveness analysis.

Journal: Health technology assessment (Winchester, England)

Published: March 21, 2024

A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.

A Blueprint for Multi-use Disease Modeling in Health Economics: Results from Two Expert-Panel Consultations.

Journal: PharmacoEconomics

Published: March 19, 2024

Showing 1-12 of 96

Last Updated: 09/26/2026